A Phase 1b/2 Study of Agents Targeting the Mitogen-Activated Protein Kinase Pathway in Patients with Advanced Gastrointestinal Malignancies (HERKULES-3)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Erasca, Inc
Start Date
November 22, 2021
End Date
August 11, 2026
Administered By
Duke Cancer Institute
Awarded By
Erasca, Inc
Start Date
November 22, 2021
End Date
August 11, 2026